Skip to main content

Generics

  • Purdue Pharma launches RxPATROL Twitter feed

    STAMFORD, Conn. — Purdue Pharma has launched a new way for fighting pharmacy crime, the drug maker said Tuesday.

  • Sagent Q3 net revenue jumps 94%

    SCHAUMBURG, Ill. — Third-quarter net revenue for Sagent Pharmaceuticals jumped 94% to $41.3 million, thanks to several new product launches during the period.

    Gross profit for the quarter ended Sept. 30 was $6.9 million, or 16.8% of net revenues, compared with $2.7 million, or 12.9% of net revenues, in the year-ago period.

  • FDA appoints new commissioner's chief of staff

    SILVER SPRING, Md. — The Food and Drug Administration has appointed a new chief of staff for commissioner Margaret Hamburg, according to a letter sent to agency employees Monday.

    In the letter, Hamburg announced the appointment of Lisa Barclay. Barclay, currently a partner at the Washington law firm Zuckerman Spaeder, will replace Molly Muldoon, who was previously chief of staff and more recently the agency's acting COO.

  • Bill to incentivize generic use in Medicaid introduced in Congress

    WASHINGTON — A bill proposed in Congress would give states incentives for using generic drugs through the Medicaid program.

  • Branded generics offer new ways to reformulate drugs

    In the classic “Arabian Nights” tale of Aladdin and his magic lamp, the evil sorcerer who made Aladdin retrieve the lamp containing the genie attempts to get it back by tricking Aladdin’s wife into giving it to him by roaming through the streets offering to trade “new lamps for old.”


  • With 2012 near, generics still face challenges

    In February, Drug Store News discussed three issues concerning generic drugs that would figure prominently throughout the year: drug safety, user fees and patent settlements.


  • Marsh offers Diabetes Care program

    INDIANAPOLIS — Marsh Supermarkets is offering a new program for patients with diabetes, according to the Indianapolis-based chain's website.

    Under Marsh's Diabetes Care program, patients who bring a new prescription to a Marsh supermarket pharmacy or transfer an existing one will receive up to a 30-day supply of qualifying generic diabetes medications for free, as well as free universal lancets.

    The medications include glipizide, metformin, glimepiride and glyburide. The program is available through the end of May 2012.

  • FDA approves generic version of Merck's Elestat ophthalmic solution

    ALLEGAN, Mich. — The Food and Drug Administration has approved a drug made by Perrigo and PharmaForce/Luitpold Pharmaceuticals for treating eye allergies, Perrigo said.

    The FDA approved epinastine hydrochloride ophthalmic solution in the 0.05% strength. The drug is a generic version of Merck's Elestat, used to treat ocular itching related to allergic conjunctivitis.

    Annual sales for the branded version before the appearance of generics on the market were $30 million, according to Wolters Kluwer.

X
This ad will auto-close in 10 seconds